Diabetes, Vol 37, Issue 4 398-404, Copyright © 1988 by American Diabetes Association
Reversible impairment of glucose-induced insulin secretion in SHR/N-cp rats. Genetic model of type II diabetes
NR Voyles, AM Powell, KI Timmers, SD Wilkins, SJ Bhathena, C Hansen, OE Michaelis and L Recant
Diabetes Research Laboratory, Veterans Administration Medical Center, Washington, DC 20422.
The SHR/N-cp rat is a new genetically obese model for non-insulin-dependent
diabetes mellitus. Expression of the diabetes is enhanced by a high-sucrose
(54%) diet. After 4 wk on the diet, the cp/cp rats weigh significantly more
than their +/? controls, have postprandial hyperglycemia (greater than 400
mg/dl), and are hyperinsulinemic, with immunoreactive insulin (IRI) levels
10- to 20-fold greater than controls. Total pancreatic IRI tends to be
increased 1.6-fold in the cp/cp rats (although not significantly). There is
no increase in pancreatic proinsulin content as a percent of total IRI.
Studies of in vitro pancreatic function were carried out with the isolated
nonrecirculating perfused pancreas method. The cp/cp rats (n = 10) showed
impaired or absent IRI responses to 16.5 mM glucose, whereas +/? rats (n =
9) responded with classic biphasic curves. Comparison of insulin secreted
in 20 min revealed a greater than 53% decrease in IRI secretion in cp/cp
rats (P less than .05). A paradoxical hypersecretion of IRI at glucose
concentrations of 0-2.7 mM was noted in cp/cp but not lean rats, i.e., 1.8
+/- 0.2 mU/min IRI in cp/cp rats vs. 0.04 +/- 0.007 mU/min in +/? rats.
Perfusion of pancreases for 45 min with buffers containing no glucose
resulted in restoration of a normal biphasic IRI response to 16.5 mM
glucose in the cp/cp rats, whereas response in the lean rats was markedly
reduced. Brisk IRI responses to 10 mM arginine in buffers with no glucose
also occurred in cp/cp but not +/? rats. Glucagon secretion was relatively
suppressed in the cp/cp rats.(ABSTRACT TRUNCATED AT 250 WORDS)